Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.55 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | AGER | Q15109 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.49 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31513532 | 1.00 | PARP1 (0.58) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL939161 | 0.88 | KDM4E (0.74) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL30728633 | 0.88 | KDM4E (0.74) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL5158054 | 0.88 | KDM4E (0.52) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL6333183 | 0.88 | KDM4E (0.74) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL2488255 | 0.86 | PARP1 (0.53) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL11755061 | 0.83 | P2RX7 (0.62) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL15652068 | 0.83 | KDM4E (0.47) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL5902495 | 0.83 | PARP1 (0.50) | PARP1KDM4EMAPTALDH1A1TSHR | |
| SCHEMBL9220766 | 0.83 | PARP1 (0.50) | PARP1KDM4EMAPTALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250144081-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | THE SCRIPPS RESEARCH INSTITUTE | 2025-05-08 | — | — | US | claimed |
| CN-119390688-A | Quinoline amide derivative, and preparation method and application thereof | 华南农业大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119039684-A | Polymer-based PTC composite material based on pi-pi interaction, preparation method and application | 四川大学 | 2024-11-29 | — | — | CN | claimed |
| CN-118666933-A | Quinoline amide organogelator and preparation method and application thereof | 上海应用技术大学 | 2024-09-20 | — | — | CN | claimed |
| CN-116103517-B | Extraction solvent and extraction method for extracting and separating titanium and/or iron from acidic solution containing titanium and/or iron | 哈尔滨工业大学（威海） | 2024-04-26 | — | — | CN | claimed |
| CN-117820776-A | Polymer-based composite material with low dielectric constant and low dielectric loss, and preparation method and application thereof | 四川大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117447446-A | Pyridine bisamide derivative, and preparation method and application thereof | 山东京博农化科技股份有限公司 | 2024-01-26 | — | — | CN | claimed |
| EP-3841168-B1 | METHODS OF MAKING POLYMER COMPOSITIONS WITH ENHANCED ELASTICITY BY EMPLOYING VTP AND HMP CATALYST SYSTEMS IN PARALLEL PROCESSES | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2024-01-17 | — | — | EP | claimed |
| CN-114790167-B | Preparation method of 2, 3-dichloropyridine | 北京弗莱明科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| US-11739169-B2 | Solubility improvement of non-metallocene transition metal complexes in aliphatic hydrocarbon solvents | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-08-29 | — | — | US | claimed |
| JP-2004502669-A | — | — | 2004-01-29 | — | — | JP | claimed |
| EP-1353898-A2 | COMPOUNDS TO TREAT ALZHEIMER'S DISEASE | Elan Pharmaceuticals, Inc. (US) | 2003-10-22 | — | — | EP | claimed |
| US-6472349-B1 | Pyridine-2,3-dicarboxylic acid diamides | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-29 | — | — | US | claimed |
| CN-1349507-A | Pyridine-2,3-dicarboxylic acid diamides | BASF AG (DE) | 2002-05-15 | — | — | CN | claimed |
| WO-2002002512-A2 | COMPOUNDS TO TREAT ALZHEIMER'S DISEASE | ELAN PHARMACEUTICALS, INC. (US) | 2002-01-10 | — | — | WO | claimed |
| WO-1998033786-A9 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | — | 1998-12-30 | — | — | WO | claimed |
| US-5843868-A | Pryidine-2,3-dicarboxylic acid diamide derivatives and herbicides comprising said derivatives as active ingredient | NIHON NOHYAKU CO., LTD. (JP) | 1998-12-01 | — | — | US | claimed |
| EP-0799825-A1 | Pyridine-2,3-dicarboxylic acid diamide derivatives and herbicides comprising said derivatives as active ingredient | NIHON NOHYAKU CO., LTD. (JP) | 1997-10-08 | — | — | EP | claimed |
| EP-0634400-B1 | PYRIDINECARBOXIMIDAMIDE COMPOUND AND USE THEREOF | KIRIN BREWERY (JP) | 1997-04-02 | — | — | EP | claimed |
| US-3947442-A | Method for producing heterocyclic acid anhydrides and pyrimidinediones | THE SHERWIN-WILLIAMS COMPANY (US) | 1976-03-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250144081-A1 | METHODS FOR REDUCING ALCOHOL, DRUG, AND FOOD INTAKE | LIPC, PNLIP, LPL | PARP1 1903/4885KDM4E 1118/4885MAPT 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.